» Articles » PMID: 37397540

Wnt Signaling: Essential Roles in Osteoblast Differentiation, Bone Metabolism and Therapeutic Implications for Bone and Skeletal Disorders

Overview
Journal Genes Dis
Date 2023 Jul 3
PMID 37397540
Authors
Affiliations
Soon will be listed here.
Abstract

Wnt signaling executes an indispensable performance in osteoblast differentiation, bone development, homeostasis, and remodeling. Wnt signals trigger the intracellular Wnt signaling cascade to initiate regulating the implication of β-catenin in the bone environment. Going through the novel discoveries done via high-throughput sequencing technologies on genetic mouse models, we highlighted the significant contribution of Wnt ligands, co-receptors, inhibitors, their related skeletal phenotypes in mouse models and the similar bone disorders clinically observed in human beings. Moreover, the crosstalk between Wnt signaling pathway and BMP, TGF-β, FGF, Hippo, Hedgehog, Notch and PDGF signaling pathways is thoroughly demonstrated to be the underlying gene regulatory network that orchestrates osteoblast differentiation and bone development. We also introspected the significance of Wnt signaling transduction in the reorganization of cellular metabolism by stimulating glycolysis, glutamine catabolism, and fatty acid oxidation in osteoblast-lineage cells that display an important regulatory arbor in the cellular bioenergetics of the bone. Throughout this evaluation, most to date therapeutical approaches towards osteoporosis and other bone maladies found in human beings, are formulated with an aspiration to holistically revamp the present clinical applications involving various monoclonal antibodies therapies that lack specificity, efficacy, and safety into more requisite advanced therapeutics that satisfy these three requirements for further clinical considerations. Conclusively, our review provides comprehensive scientific findings related to the fundamental significance of Wnt signaling cascades in skeletal system and the underlying gene regulatory network with other signaling pathways enlightening researchers with the possibility to further integrate the identified target molecules into therapeutic strategies for skeletal disorders treatment in the clinic.

Citing Articles

Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.

Zhuang H, Lin Y, Lin C, Zheng M, Yao X, Xu Y Am J Transl Res. 2025; 17(1):416-428.

PMID: 39959199 PMC: 11826214. DOI: 10.62347/XSOV4523.


Targeted treatment for craniopharyngioma.

Stec N, Barker 2nd F, Brastianos P J Neurooncol. 2025; .

PMID: 39951179 DOI: 10.1007/s11060-025-04942-0.


Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy.

Luo C, Dai Z, He W, He Y, Yang P, Huang M Front Nutr. 2025; 12:1508695.

PMID: 39917743 PMC: 11798809. DOI: 10.3389/fnut.2025.1508695.


Nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing protein 5 affects the progression of periodontitis by regulating the function of periodontal membrane cells.

Lyu P, Liu J, Ouyang X, Wang Y, Liu W, Zhong J J Dent Sci. 2025; 20(1):325-334.

PMID: 39873066 PMC: 11762624. DOI: 10.1016/j.jds.2024.07.008.


Advancements in Bone Replacement Techniques-Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ).

Bovari-Biri J, Miskei J, Kover Z, Steinerbrunner-Nagy A, Kardos K, Maroti P Cells. 2025; 14(2).

PMID: 39851573 PMC: 11763601. DOI: 10.3390/cells14020145.


References
1.
Swierkot J, Gruszecka K, Matuszewska A, Wiland P . Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. Arch Immunol Ther Exp (Warsz). 2015; 63(5):397-404. PMC: 4572055. DOI: 10.1007/s00005-015-0338-x. View

2.
Frey J, Li Z, Ellis J, Zhang Q, Farber C, Aja S . Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol Cell Biol. 2015; 35(11):1979-91. PMC: 4420919. DOI: 10.1128/MCB.01343-14. View

3.
Zheng H, Forgetta V, Hsu Y, Estrada K, Rosello-Diez A, Leo P . Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature. 2015; 526(7571):112-7. PMC: 4755714. DOI: 10.1038/nature14878. View

4.
Bhat B, Allen K, Liu W, Graham J, Morales A, Anisowicz A . Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling. Gene. 2007; 391(1-2):103-12. DOI: 10.1016/j.gene.2006.12.014. View

5.
Li X, Ominsky M, Villasenor K, Niu Q, Asuncion F, Xia X . Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis. Endocrinology. 2017; 159(1):260-271. DOI: 10.1210/en.2017-00794. View